Ratings by Chardan
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 10/20/2026 | Gautam Chukka | Tvardi Therapeutics Inc | TVRD | New Coverage | Buy (N/A) |
8.00 (N/A) |
0.97 (0.99) |
2.06% | Details |
| 10/19/2026 | Keay Nakae | Silence Therapeutics | SLN | Downgrade | Neutral (Buy) |
20.00 (N/A) |
8.68 (19.61) |
125.92% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 1,001 more... | |||||||||
